EMD 1204831
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EMD 1204831, covering 2013-10-22 to 2013-10-22. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors [Phase 1]